How is it that the wealthiest country on Earth could be forced to resort to a Third World solution to treat a disease as dangerous as TB?

The report of the High-Level Panel of Eminent Persons on the Post-2015 Development Agenda identified tuberculosis investments as highly cost-effective and proposed a specific sub-target on TB as part of a set of goals that could be used to guide development for the 15 years after 2015.

Two Indians die of TB every three minutes. Why are 330,000 Indians dying from a disease that is completely curable?

Review first year’s progress toward implementing the African Union Roadmap.

New report shows that strong partnership between African and G8 governments has delivered impressive results but gaps remain in efforts to improve health across the continent.

A clinical trial to assess a 9-month standardised treatment regimen for MDR-TB has begun in South Africa, Ethiopia and Vietnam.

Re: Marketing and use of QuantiFERON-TB Gold for active TB in India and high TB burden countries

New TB target proposed to guide progress after 2015: zero new TB infections, zero TB deaths, zero TB suffering and zero TB stigma and discrimination.

Researchers have successfully developed and tested a combination of simple clinical, radiological and laboratory tools to diagnose smear-negative tuberculosis.

A handheld diagnostic device that Massachusetts General Hospital (MGH) investigators first developed to diagnose cancer has been adapted to rapidly diagnose tuberculosis and other important infectious bacteria.